Literature DB >> 26479860

Evolutionarily conserved exon definition interactions with U11 snRNP mediate alternative splicing regulation on U11-48K and U11/U12-65K genes.

Elina H Niemelä1, Jens Verbeeren1, Prosanta Singha1, Visa Nurmi1, Mikko J Frilander1.   

Abstract

Many splicing regulators bind to their own pre-mRNAs to induce alternative splicing that leads to formation of unstable mRNA isoforms. This provides an autoregulatory feedback mechanism that regulates the cellular homeostasis of these factors. We have described such an autoregulatory mechanism for two core protein components, U11-48K and U11/U12-65K, of the U12-dependent spliceosome. This regulatory system uses an atypical splicing enhancer element termed USSE (U11 snRNP-binding splicing enhancer), which contains two U12-type consensus 5' splice sites (5'ss). Evolutionary analysis of the USSE element from a large number of animal and plant species indicate that USSE sequence must be located 25-50 nt downstream from the target 3' splice site (3'ss). Together with functional evidence showing a loss of USSE activity when this distance is reduced and a requirement for RS-domain of U11-35K protein for 3'ss activation, our data suggests that U11 snRNP bound to USSE uses exon definition interactions for regulating alternative splicing. However, unlike standard exon definition where the 5'ss bound by U1 or U11 will be subsequently activated for splicing, the USSE element functions similarly as an exonic splicing enhancer and is involved only in upstream splice site activation but does not function as a splicing donor. Additionally, our evolutionary and functional data suggests that the function of the 5'ss duplication within the USSE elements is to allow binding of two U11/U12 di-snRNPs that stabilize each others' binding through putative mutual interactions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26479860      PMCID: PMC4829294          DOI: 10.1080/15476286.2015.1096489

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  54 in total

1.  Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway.

Authors:  M L Hastings; A R Krainer
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

2.  The splicing of U12-type introns can be a rate-limiting step in gene expression.

Authors:  Abhijit A Patel; Matthew McCarthy; Joan A Steitz
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

3.  The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.

Authors:  Cindy L Will; Claudia Schneider; Markus Hossbach; Henning Urlaub; Reinhard Rauhut; Sayda Elbashir; Thomas Tuschl; Reinhard Lührmann
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

4.  The divergent U12-type spliceosome is required for pre-mRNA splicing and is essential for development in Drosophila.

Authors:  Leo R Otake; Petra Scamborova; Carl Hashimoto; Joan A Steitz
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

5.  Interactions of Arabidopsis RS domain containing cyclophilins with SR proteins and U1 and U11 small nuclear ribonucleoprotein-specific proteins suggest their involvement in pre-mRNA Splicing.

Authors:  Zdravko J Lorkovic; Sergiy Lopato; Monika Pexa; Reinhard Lehner; Andrea Barta
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

6.  Global analysis of the nuclear processing of transcripts with unspliced U12-type introns by the exosome.

Authors:  Elina H Niemelä; Ali Oghabian; Raymond H J Staals; Dario Greco; Ger J M Pruijn; Mikko J Frilander
Journal:  Nucleic Acids Res       Date:  2014-05-21       Impact factor: 16.971

7.  SR proteins control a complex network of RNA-processing events.

Authors:  Todd Bradley; Malcolm E Cook; Marco Blanchette
Journal:  RNA       Date:  2014-11-20       Impact factor: 4.942

8.  Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.

Authors:  Vikas Madan; Deepika Kanojia; Jia Li; Ryoko Okamoto; Aiko Sato-Otsubo; Alexander Kohlmann; Masashi Sanada; Vera Grossmann; Janani Sundaresan; Yuichi Shiraishi; Satoru Miyano; Felicitas Thol; Arnold Ganser; Henry Yang; Torsten Haferlach; Seishi Ogawa; H Phillip Koeffler
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

9.  Nuclear export and retention signals in the RS domain of SR proteins.

Authors:  Demian Cazalla; Jun Zhu; Lisa Manche; Elisabeth Huber; Adrian R Krainer; Javier F Cáceres
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  A novel intra-U1 snRNP cross-regulation mechanism: alternative splicing switch links U1C and U1-70K expression.

Authors:  Tanja Dorothe Rösel-Hillgärtner; Lee-Hsueh Hung; Ekaterina Khrameeva; Patrick Le Querrec; Mikhail S Gelfand; Albrecht Bindereif
Journal:  PLoS Genet       Date:  2013-10-17       Impact factor: 5.917

View more
  4 in total

1.  MiasDB: A Database of Molecular Interactions Associated with Alternative Splicing of Human Pre-mRNAs.

Authors:  Yongqiang Xing; Xiujuan Zhao; Tao Yu; Dong Liang; Jun Li; Guanyun Wei; Guoqing Liu; Xiangjun Cui; Hongyu Zhao; Lu Cai
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

2.  Alternative exon definition events control the choice between nuclear retention and cytoplasmic export of U11/U12-65K mRNA.

Authors:  Jens Verbeeren; Bhupendra Verma; Elina H Niemelä; Karen Yap; Eugene V Makeyev; Mikko J Frilander
Journal:  PLoS Genet       Date:  2017-05-26       Impact factor: 5.917

3.  Mutations in the U11/U12-65K protein associated with isolated growth hormone deficiency lead to structural destabilization and impaired binding of U12 snRNA.

Authors:  Antto J Norppa; Tuuli M Kauppala; Harri A Heikkinen; Bhupendra Verma; Hideo Iwaï; Mikko J Frilander
Journal:  RNA       Date:  2017-12-18       Impact factor: 4.942

4.  SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma.

Authors:  Yu-Ting Zhan; Lei Li; Ting-Ting Zeng; Ning-Ning Zhou; Xin-Yuan Guan; Yan Li
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.